Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Z-ajoene causes cell cycle arrest at G2/M and decrease of telomerase activity in HL-60 cells].

Ying Ye1, Hua-yu Yang, Jun Wu

  • 1Key Laboratory of Natural and Bionic Medicines, School of Medicine, Peking University, Beijing 100083, China.

Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|January 28, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanism of hepatocytes differentiation and dedifferentiation in liver regeneration: Process and exploration.

Hepatobiliary & pancreatic diseases international : HBPD INT·2022
Same author

Research progress and prospects of circulating tumor cells in hepatocellular carcinoma.

Hepatobiliary & pancreatic diseases international : HBPD INT·2022
Same author

Novel 3D preclinical model systems with primary human liver cells: Recent progresses, applications and future prospects.

Hepatobiliary & pancreatic diseases international : HBPD INT·2021
Same author

γ-glutamyl transferase-to-platelet ratio based nomogram predicting overall survival of gallbladder carcinoma.

World journal of gastrointestinal oncology·2020
Same author

Liver injury in COVID-19: What do we know now?

Hepatobiliary & pancreatic diseases international : HBPD INT·2020
Same author

Transarterial radioembolization with Yttrium-90: current status and future prospects.

Gastroenterology report·2020

Z-ajoene effectively inhibits HL-60 cancer cell proliferation by blocking mitosis at the G(2)/M phase. This compound also suppresses telomerase activity, indicating potent anti-cancer properties.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pharmacology

Background:

  • Leukemia is a significant health concern, necessitating novel therapeutic strategies.
  • Understanding the molecular mechanisms of anti-cancer agents is crucial for drug development.

Purpose of the Study:

  • To elucidate the molecular mechanisms behind Z-ajoene's anti-mitotic and telomerase inhibitory effects.
  • To investigate Z-ajoene's impact on cell cycle regulation in HL-60 leukemia cells.

Main Methods:

  • MTT assay for proliferation inhibition.
  • Flow cytometry for cell cycle analysis (mitotic block).
  • Immunoblotting for cell cycle proteins (cyclin B1, p34(cdc2)).
  • TRAP-silver stain assay for telomerase activity.
  • RT-PCR for telomerase gene expression (hTRT, TP1).

Related Experiment Videos

Main Results:

  • Z-ajoene significantly inhibited HL-60 cell proliferation.
  • Z-ajoene induced a dose-dependent G(2)/M phase mitotic block, peaking at 10 hours.
  • Increased cyclin B1 and decreased p34(cdc2) expression were observed.
  • Z-ajoene reduced telomerase activity and suppressed hTRT and TP1 mRNA levels.

Conclusions:

  • Z-ajoene exhibits potent anti-cancer activity against HL-60 cells.
  • The anti-cancer effects are likely mediated by G(2)/M phase cell cycle arrest and telomerase inhibition.